Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07071623
Recruiting
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Phase 3 · Kenya, Uganda, South Africa · 30 sites
Registry update: 20 Oct 2026
NCT07229664
Recruiting
Vinpocetine in Patients With Parkinsonian Disease
Phase 2/3 · Egypt · 1 site
Registry update: 10 Dec 2025
NCT07186101
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2 · Austria, Brazil, Canada, China, Germany, Denmark, Spain, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Romania, United States · 147 sites
Registry update: 4 Nov 2026
NCT07617272
Recruiting
Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore
Phase 2 · Sweden · 2 sites
Registry update: 1 Jun 2026
NCT07383324
Recruiting
Heat Stress in Individuals With Schizophrenia
Not applicable · Canada · 1 site
Registry update: 23 Apr 2026
NCT07189195
Recruiting
TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
Phase 1 · United States · 1 site
Registry update: 16 Jul 2026
NCT07027436
Recruiting
Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
Phase 3 · Canada · 2 sites
Registry update: 17 Sept 2026
NCT07220876
Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Not applicable · United States, South Africa · 14 sites
Registry update: 7 Oct 2026
NCT07555665
Recruiting
REal Word aPpLicAtion of Molecular Based Endometrial Cancer Classification
Not applicable · Italy · 1 site
Registry update: 29 Apr 2026
NCT07428356
Recruiting
Histotripsy for Ablation of Liver Tumours in Asia
Not applicable · Singapore · 3 sites
Registry update: 8 Oct 2026
NCT06656598
Recruiting
Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer
Phase 2 · France · 48 sites
Registry update: 11 Aug 2026
NCT06929091
Recruiting
Effect of Prenatal and Postnatal Intervention Strategies on Breastfeeding Outcomes in Women With Excessive Weight (Ready, Set, Nourish Study)
Not applicable · United States · 1 site
Registry update: 24 Sept 2026
NCT07711223
Recruiting
Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1)
Phase 1/2 · China · 1 site
Registry update: 17 Jul 2026
NCT07259928
Recruiting
Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
Phase 2 · Germany, United Kingdom · 2 sites
Registry update: 2 Dec 2025
Conflicting statuses (not updated in the registry for 11 months)
NCT07225816
Recruiting
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Phase 1 · United States · 1 site
Registry update: 21 Jul 2026
NCT07166939
Recruiting
45th Multicenter Airway Research Collaboration
Phase 4 · United States · 1 site
Registry update: 17 Apr 2026
NCT07263178
Recruiting
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
Not applicable · South Korea · 1 site
Registry update: 4 Dec 2025
NCT07211542
Recruiting
A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
Phase 2 · China · 1 site
Registry update: 8 Apr 2026
NCT07756437
Recruiting
Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer
Not applicable · Belgium · 1 site
Registry update: 10 Aug 2026
NCT07154511
Recruiting
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Phase 1/2 · United States · 1 site
Registry update: 12 Nov 2025

Ordered by registry start date. Freshness and sponsorship never change the order.